I63.0 I63.1 I63.2 I63.3 I63.4 I63.5
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Awareness about the project No severe disability before index stroke (mRS 0-1) Insurance in the statutory health insurance There are at least one of the following risk factors: arterial hypertension, hypercholesterolemia, diabetes mellitus, smoking, atrial fibrillation written consent to study participation
Exclusion criteria
Exclusion criteria: Age 3 at the time of screening for the study Former stroke (ischemic insult or cerebral hemorrhage, former TIAs are not an exclusion cause) Life expectancy <3 years (due to the time of the screening of known diseases) Alcohol, medications or drug addiction as assessed by the study doctor Severe psychiatric illness as assessed by the study physician Missing family doctor and no willingness to select a family doctor at short notice No consent of the responsible family doctor to participate in the study Nursing home or long-term care before the index stroke Existing legal care of the patient Inadequate knowledge of German, very severe aphasia Lack of availability of the clinic for follow-up No consent to attend the clinic visits after 1, 3, 6 and 9 months Rare stroke cause for which there are no evidence-based recommendations for secondary prophylaxis (dissection, vasculitis, drug-associated strokes, strokes during pregnancy, etc.) Participation in drug law (AMG) study Other reasons according to the study doctor, which can not guarantee the application or implementation of the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of combined outcome in recurrent stroke, myocardial infarction or death within one year of stroke | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of regulatory risk factors (hypertension, diabetes mellitus, hypercholesterolemia, smoking, diet, physical activity) at one year after stroke • Therapy adherence regarding antithrombotic medication at one year post stroke • Rate of hospital admissions within one year of stroke • Rate of complications (cognitive impairment, depression and anxiety, falls) or their treatment at the time of one year after stroke • Quality of life at the time of one year after stroke • Follow-up costs in the first year after stroke These endpoints are measured using the following tools: Cognitive limitations MoCA test Depression / Anxiety PHQ-9 / GAD7 Medication Adherence Medication Adherence Rating Scale (MARS) Quality of life EQ-5D-5L Physical Activity IPAQ / Pedometer Diet MONICA, nutrition questionnaire All other secondary endpoints are determined by standardized interviews, examinations or laboratory parameters. | — |
Countries
Germany
Contacts
Klinikum Ludwigshafen am Rhein